Chronic migraine management with onabotulinumtoxinA and anti-CGRP/R monoclonal antibodies in an Italian real-world setting: update on therapeutic appropriateness and an emerging role of pharmacy
- DOI
- 10.3389/fphar.2026.1868002
- Published
- 2026-07-01
- Container
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1868002,
title = {Chronic migraine management with onabotulinumtoxinA and anti-CGRP/R monoclonal antibodies in an Italian real-world setting: update on therapeutic appropriateness and an emerging role of pharmacy},
author = {Damiana Scuteri and Maria Diana Naturale and Martina Pagliaro and Amelia Brescia and Adele Emanuela De Francesco and Gary W. Lawrence and Giacinto Bagetta and Maria Tiziana Corasaniti},
year = {2026},
journal = {Frontiers in Pharmacology},
doi = {10.3389/fphar.2026.1868002},
url = {https://doi.org/10.3389/fphar.2026.1868002}
}RIS
TY - JOUR TI - Chronic migraine management with onabotulinumtoxinA and anti-CGRP/R monoclonal antibodies in an Italian real-world setting: update on therapeutic appropriateness and an emerging role of pharmacy AU - Damiana Scuteri AU - Maria Diana Naturale AU - Martina Pagliaro AU - Amelia Brescia AU - Adele Emanuela De Francesco AU - Gary W. Lawrence AU - Giacinto Bagetta AU - Maria Tiziana Corasaniti PY - 2026 JO - Frontiers in Pharmacology DO - 10.3389/fphar.2026.1868002 UR - https://doi.org/10.3389/fphar.2026.1868002 ER -
APA
Scuteri, D., Naturale, M. D., Pagliaro, M., Brescia, A., Francesco, A. E. D., Lawrence, G. W., Bagetta, G., & Corasaniti, M. T. (2026). Chronic migraine management with onabotulinumtoxinA and anti-CGRP/R monoclonal antibodies in an Italian real-world setting: update on therapeutic appropriateness and an emerging role of pharmacy. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1868002
Source records
- crossref · retrieved 2026-09-24T23:45:34.860Z